The Potential Role of Xanthohumol in SARS-CoV-2 Treatment—Globally Accessible and Economically Viable by Caplin M, Chen L

Get full text

Peptide Receptor Radionuclide Treatment and (131)I-MIBG in the management of patients with metastatic/progressive phaeochromocytomas and paragangliomas by Nastos, K, Cheung, V, Toumpanakis, C, Navalkissoor, S, Quigley, A, Caplin, M, Khoo, B

Novel markers of cell kinetics to evaluate progression from cirrhosis to hepatocellular carcinoma. by Quaglia, A, McStay, M, Stoeber, K, Loddo, M, Caplin, M, Fanshawe, T, Williams, G, Dhillon, A

Gastroenteropancreatic neuroendocrine tumours. by Modlin, I, Oberg, K, Chung, D, Jensen, RT, de Herder, W, Thakker, R, Caplin, M, Delle Fave, G, Kaltsas, G, Krenning, E, Moss, S, Nilsson, O, Rindi, G, Salazar, R, Ruszniewski, P, Sundin, A

Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). by Ramage, J, Ahmed, A, Ardill, J, Bax, N, Breen, D, Caplin, M, Corrie, P, Davar, J, Davies, A, Lewington, V, Meyer, T, Newell-Price, J, Poston, G, Reed, N, Rockall, A, Steward, W, Thakker, R, Toubanakis, C, Valle, J, Verbeke, C, Grossman, AB

Rapid and sustained relief from the symptoms of carcinoid syndrome: results from an open 6-month study of the 28-day prolonged-release formulation of lanreotide. by Ruszniewski, P, Ish-Shalom, S, Wymenga, M, O'Toole, D, Arnold, R, Tomassetti, P, Bax, N, Caplin, M, Eriksson, B, Glaser, B, Ducreux, M, Lombard-Bohas, C, de Herder, W, Delle Fave, G, Reed, N, Seitz, J, Van Cutsem, E, Grossman, A, Rougier, P, Schmidt, W, Wiedenmann, B